Sandu Pharmaceuticals Ltd
Tue 17/11/2026,16:1:0 | BSE : SANDUPHQ
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 36.75
Previous Close
₹ 36.93
Volume
3506
Mkt Cap ( ₹ Cr)
₹ 35.31
High
₹ 37.98
Low
₹ 36.30
52 Week High
₹ 50.00
52 Week Low
₹ 30.00
Book Value Per Share
₹ 45.44
Dividend Yield
₹ 2.73
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Sandu Pharmaceuticals Ltd
Your Vote -
Buy
33.33%
Hold
33.33%
Sell
33.33%
33.33%
3 users have voted
Option Chain
Analyzes market sentiment, predicts Sandu Pharmaceuticals Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Sandu Pharma. Q2 net profit jumps 51.92% at Rs 0.79 cr
-
Sandu Pharma. - Statement Of Deviation And Variation Of Funds For Q Ended 30Th September 2026
-
Sandu Pharma. - Financial Results For Q And Half Year Ended 30Th Sept 2026
-
Sandu Pharma. - Board Meeting Outcome for Outcome Of The Board Meeting Dated 14Th November 2026
-
Sandu Pharma. - Board Meeting Intimation for Approval Of Unaudited Financials For Quarter And Half Year Ended 30Th September
-
Sandu Pharma. has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026
-
Sandu Pharma. - Intimation Regarding Change In Name Of Director From Dr Neeti Madan Kapre To Dr Neeti Gupta.
-
Sandu Pharma. - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
Sandu Pharma. - Intimation To The Holders Of Physical Securities To Furnish PAN And KYC Details
-
Sandu Pharma. - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Sandu Pharma. - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s
-
Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Sandu Pharma. - Shareholder Meeting / Postal Ballot-Outcome of AGM
-
Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Sandu Pharma. - Shareholder Meeting / Postal Ballot-Scrutinizer's Report
-
Sandu Pharma. - Announcement Under Regulation 30-Letter To Shareholder On Annual Report Weblink Whose Email Ids Are Not Regis
-
Sandu Pharma. - Reg. 34 (1) Annual Report.
-
Sandu Pharma. - Annual General Meeting To Be Held On 11Th September 2026 At 04:30 Pm Through Video Conferencing ('VC')/ Othe
Key fundamentals
Evaluate the intrinsic value of Sandu Pharmaceuticals Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 43.6734 | 42.0172 | 40.5953 | 39.2444 | 36.4746 |
| Liabilities | 43.6734 | 42.0172 | 40.5953 | 39.2444 | 36.4746 |
| Equity | 9.661 | 9.661 | 9.661 | 9.661 | 8.8107 |
| Gross Profit | 3.0002 | 2.7622 | 2.2973 | 2.4893 | 2.874 |
| Net Profit | 1.7662 | 1.5489 | 1.4606 | 1.5239 | 1.5893 |
| Cash From Operating Activities | 6.1155 | 0.9504 | 0.7614 | 0.2212 | 0.9487 |
| NPM(%) | 2.52 | 2.3 | 2.17 | 2.33 | 2.42 |
| Revenue | 69.9345 | 67.1924 | 67.2807 | 65.349 | 65.5005 |
| Expenses | 66.9343 | 64.4302 | 64.9834 | 62.8597 | 62.6265 |
| ROE(%) | 4.02 | 3.52 | 3.32 | 3.47 | 3.62 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Sandu Pharmaceuticals Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 770.00 | -1.91 | 15.26 | 20.86 | -26.19 | 0.65 |
| Lotus Eye Hospital and Institute Ltd | 103.25 | 1.03 | 477.09 | 76.01 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 9.00 | 0.11 | 0.00 | 157.82 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 561.45 | 1.33 | 0.00 | 81.44 | -363.14 | 0.00 |
Company Info
The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.
The name "Sandu" leads in this roll call of honour. 10th May 1899 was the day Sandu Brothers chose to revolutionise the manufacture of Ayurvedic medicines. Commitment to the spread of Ayurveda and bringing health even to the poor were the lofty ideals that have been the foundation of the success of Sandu. High quality made Sandu medicines popular. Started on 10th May 1899 at Thakurdwar, Mumbai, the factory was later shifted to Chembur to cater to growing demand. Sandu is now a name established throughout India and has earned acceptance even beyond its borders and not in the Indian diaspora alone. Over 120 years, the secret of Sandu's success lies in our commitment to quality and firm adherence to the basic tenets of Ayurveda. Today, the fourth generation of Sandu at the helm implements a seamless confluence between tradition and modern pharmaceutical practices. We are growing, but without compromising on the quality in any way.Sandu is a benchmark of Quality amongst doctors, practitioners, and common people alike. Our commitment to quality is reflected in the ISO 9001:2000 certification we have earned for our Group operations which include our manufacturing units at New Mumbai and Goa as well as our full-fledged research unit - Sandu Research Foundation Pvt Ltd. While we rigorously follow traditional formulations, our manufacturing processes are totally aseptic and state-of-the-art with no human contact during the manufacturing process. Today, when allopathic medicines dominate the market, Sandu takes deserved pride in being known as the manufacturer of Ayurvedic Medicines with Visible Efficacy.
Read More
Parent Organisation
Sandu Pharmaceuticals Ltd.
Founded
15/11/1985
Managing Director
NSE Symbol
FAQ
The current price of Sandu Pharmaceuticals Ltd is
The 52-week high for Sandu Pharmaceuticals Ltd is
The market capitalization of Sandu Pharmaceuticals Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Sandu Pharmaceuticals Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Sandu Pharmaceuticals Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Sandu Pharmaceuticals Ltd shares.
The CEO of Sandu Pharmaceuticals Ltd is , who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.